AARTIPHARM.NSAARTIPHARM.NSNSE
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+213.3%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

3Y CAGR
+213.3%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
30.7x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 202584.94%
Q3 2025-35.25%
Q2 2025-23.94%
Q1 20258.59%
Q4 202417.99%
Q3 202440.92%
Q2 2024-25.74%
Q1 20244.06%
Q4 20238.91%
Q3 20230.06%
Q2 202325.68%
Q1 2023-25.76%
Q4 20222.76%
Q3 20223.41%
Q2 2022-16.52%
Q1 2022-0.00%
Q4 20210.00%
Q3 20210.00%
Q2 20210.00%